Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery
Year: 2021
Type: review
Institution: Duke University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: Leveraging Functional Selectivity in the Neurotensin Receptor 1-Mediated Treatment of Addiction, Leveraging Functional Selectivity in the Neurotensin Receptor 1-Mediated Treatment of Addiction, Biased Agonism at Neurotensin Receptor 1 for the Treatment of Methamphetamine Addiction, Development of SBI-553, an allosteric modulator of NTR1, for the treatment of substance use disorders, Akt/GSK-3 Signaling Cascade and the Actions of Dopamine
OpenAlex ID: W3129083073
